Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$33.34 -0.07 (-0.21%)
At close: Nov 11, 2026 · 4:00 PM EST

Lakefront Biotherapeutics (LKFT) Cash & Current Investments (2013 - 2026)

Updated

Lakefront Biotherapeutics (LKFT) posted Cash & Current Investments of $77 million for the quarter ended Mar 31, 2026, down 97.8% from $3.47 billion a year earlier and down 24.7% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Cash & Current Investments (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, Lakefront Biotherapeutics' Cash & Current Investments came in at $99.27 million, down 97.2% from the prior year.

  • Annual Cash & Current Investments has declined for six consecutive years, with a five-year compound annual growth rate of -55.8% (years ended Dec 2020 to Dec 2025).
  • In prior years, Lakefront Biotherapeutics' Cash & Current Investments was $3.59 billion in the year ended Dec 31, 2024 (-9.4%), $3.96 billion in the year ended Dec 31, 2023 (-8.1%), $4.32 billion in the year ended Dec 31, 2022 (-22.5%) and $5.57 billion in the year ended Dec 31, 2021 (-5.7%).
  • Quarterly Cash & Current Investments has run from a low of -$273.43 million in the quarter ended Dec 31, 2022 to a high of $5.75 billion in the quarter ended Sep 30, 2021 over five years.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $102.28 million (quarter ended Dec 31, 2025), -$48.4 million (quarter ended Sep 30, 2025) and -$232.96 million (quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.23 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 505.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 8.17 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 14.27 Bn
10 Lakefront Biotherapeutics 2.20 Bn 2.20 Bn 3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 3.42 Bn
Dec 31, 2025 3.52 Bn
Sep 30, 2025 3.58 Bn
Jun 30, 2025 3.63 Bn
Mar 31, 2025 3.57 Bn
Dec 31, 2024 3.24 Bn
Sep 30, 2024 -102.32 Mn
Jun 30, 2024 -136.53 Mn
Mar 31, 2024 3.84 Bn
Dec 31, 2023 4.08 Bn
Sep 30, 2023 -94.85 Mn
Jun 30, 2023 -96.29 Mn
Mar 31, 2023 4.35 Bn
Dec 31, 2022 -285.71 Mn
Sep 30, 2022 -65.76 Mn
Jun 30, 2022 -223.97 Mn
Mar 31, 2022 5.18 Bn
Dec 31, 2021 -193.66 Mn
Sep 30, 2021 5.65 Bn
Jun 30, 2021 -128.66 Mn
API Access

Lakefront Biotherapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=LKFT&period=max&api_key=YOUR_API_KEY